TFOS DEWS II Introduction

Affiliations

• ¹ Department of Ophthalmology, HealthPartners Medical Group and Clinics, St Paul, MN, USA; University of Minnesota, Minneapolis, USA. Electronic address: [email protected].
• ² Department of Ophthalmology, New Zealand National Eye Centre, The University of Auckland, Auckland, New Zealand.
• ³ Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• ⁴ University of Illinois at Chicago College of Medicine, Chicago, IL, USA.
• ⁵ Instituto de Neurociencias de Alicante, University Miguel Hernandez-CSIC, Spain; Instituto Fernandez-Vega, Oviedo University, Spain.
• ⁶ Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Vision and Eye Research Unit, Anglia Ruskin University, Cambridge, UK.
• ⁷ Office of Research on Women's Health, National Institutes of Health, Bethesda, MD, USA.
• ⁸ Keio University School of Medicine, Tokyo, Japan; Tokyo Dental College, Ichikawa General Hospital, Chiba, Japan.
• ⁹ Academic Section of Ophthalmology, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
• ¹⁰ Department of Ophthalmology, University of Louisville School of Medicine, KY, USA.
• ¹¹ Department of Ophthalmology and Visual Sciences, Federal University of São Paulo/Paulista School of Medicine, São Paulo, Brazil.
• ¹² Sjögren's Syndrome Foundation, Bethesda, MD, USA.
• ¹³ Helsinki Eye Lab and Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
• ¹⁴ Centre for Contact Lens Research, School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada.
• ¹⁵ Catholic Institute for Visual Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
• ¹⁶ Eye Institute and Affiliated Eye Center of Xiamen University and Eye Center of the Second Xiangya Hospital, Central South University, Xiamen, China.
• ¹⁷ University of Alabama at Birmingham School of Optometry, Birmingham, AL, USA.
• ¹⁸ Pharma Logic Development, San Rafael, CA, USA; Departments of Pharmacology and Ophthalmology, University of California, Davis, School of Medicine, USA.
• ¹⁹ Cornea Department, Center for Ocular Regeneration, Srujana-Center for Innovation and L V Prasad Eye Institute, Hyderabad, India.
• ²⁰ School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.
• ²¹ Vision Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK.
• ²² Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
• ²³ School of Life and Health Sciences, Aston University, Birmingham, UK.
• ²⁴ Schepens Eye Research Institute, Massachusetts Eye and Ear, and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.